Pamidronate disodium pentahydrate
CAS No. 109552-15-0
Pamidronate disodium pentahydrate( —— )
Catalog No. M23299 CAS No. 109552-15-0
Pamidronate disodium pentahydrate, a nitrogen-containing bisphosphonate, used to prevent osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 32 | In Stock |
|
| 25MG | 65 | In Stock |
|
| 50MG | 126 | In Stock |
|
| 100MG | 181 | In Stock |
|
| 200MG | 272 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePamidronate disodium pentahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPamidronate disodium pentahydrate, a nitrogen-containing bisphosphonate, used to prevent osteoporosis.
-
DescriptionPamidronate disodium pentahydrate, a nitrogen-containing bisphosphonate, used to prevent osteoporosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number109552-15-0
-
Formula Weight371.13
-
Molecular FormulaC3H21NNa2O12P2
-
Purity>98% (HPLC)
-
SolubilityH2O: 7.14 mg/mL (19.24 mM; Need ultrasonic);DMSO: insoluble
-
SMILESOC(P(O)(O)=O)(CCN)P(O)(O)=O.O.O.O.O.[Na+].[Na+].O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kubalek I, et al. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology (Oxford). 2001 Dec;40(12):1394-7.
molnova catalog
related products
-
P60c-src Substrate I...
P60c-src Substrate II
-
Dihydrobonducellin
Dihydrobonducellin has immunopharmacological activity, it significantly inhibits the production of IL-2 and IFN-gamma in activated PBMC in a concentration-dependent manner.
-
Cajanin
Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
Cart
sales@molnova.com